Financial Statements — RCON
Balance Sheet
(in millions CNY)| Metric | Q2
2026 | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 | Q2
2021 |
|---|
| Cash & Equivalents | 75.08 | 19.90 | 17.16 | 269.11 | 332.86 | 70.81 |
| Short-term Investments | 0.00 | 0.00 | 133.95 | -- | -- | -- |
| Accounts Receivable | 77.59 | 40.37 | 30.81 | 38.97 | 6.56 | 35.47 |
| Inventory | 0.09 | 1.54 | 1.86 | 4.94 | 4.96 | 0.32 |
| Total Current Assets | 49.42 | 479.20 | 425.06 | 448.80 | 72.37 | 173.85 |
| Property, Plant & Equipment | -- | -- | 23.49 | 3.78 | 26.12 | 29.08 |
| Goodwill | -- | -- | -- | 4.73 | 7.00 | -- |
| Intangible Assets | -- | -- | -- | 5.60 | 6.30 | -- |
| Total Non-current Assets* | 493.57 | (404.98) | 58.20 | (377.15) | 435.07 | 63.71 |
| Total Assets | 543.00 | 74.21 | 483.26 | 71.64 | 507.44 | 237.55 |
| Accounts Payable | 37.42 | 14.10 | 12.06 | -- | -- | -- |
| Total Current Liabilities | 11.66 | 7.14 | 9.42 | 51.55 | 56.59 | 106.82 |
| Total Non-current Liabilities* | 1.48 | 1.75 | 58.47 | 43.89 | 52.26 | 7.67 |
| Total Liabilities | 13.15 | 8.90 | 67.89 | 95.45 | 108.85 | 114.50 |
| Retained Earnings | (38.43) | (240.90) | (192.99) | (141.15) | (95.50) | (192.96) |
| Total Stockholder Equity | 66.40 | 488.54 | 425.98 | 406.52 | 63.85 | 113.50 |
* Derived from reported values
Income Statement
(in millions CNY) (except per-share rows)| Metric | Q2
2026 | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 | Q2
2021 |
|---|
| Total Revenue | 85.05 | 42.07 | 45.26 | 6.60 | 8.55 | 25.17 |
| Cost of Revenue | 56.57 | 28.71 | 4.67 | 4.70 | 6.27 | 18.45 |
| Gross Profit | 28.48 | 13.35 | 1.71 | 13.13 | 14.51 | 1.03 |
| Research & Development | 1.13 | 1.39 | 0.95 | 0.74 | 5.48 | 3.76 |
| Selling, General & Admin | 28.68 | 24.04 | 22.04 | 3.80 | 7.44 | 13.01 |
| Total Operating Expenses | 40.92 | 40.25 | 34.91 | 28.20 | 51.85 | 15.82 |
| Operating Income | (12.44) | (26.90) | (22.80) | (15.07) | (5.87) | (1.39) |
| Interest Expense | -- | -- | 1.68 | 0.17 | 0.12 | 0.15 |
| Pretax Income | -- | -- | -- | (29.86) | 17.53 | (10.14) |
| Tax Provision | -0.00 | 0.00 | 0.01 | 0.01 | 0.11 | (0.10) |
| Net Income | (0.83) | (20.59) | (3.18) | (4.33) | 17.51 | (1.37) |
| Basic EPS | (0.09) | (2.29) | (1.16) | (0.88) | 4.08 | -- |
| Diluted EPS | (0.61) | (2.29) | (1.16) | (0.13) | 0.61 | -- |
Cash Flow Statement
(in millions CNY)| Metric | Q2
2026 | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 | Q2
2021 |
|---|
| Operating Cash Flow | (1.93) | (12.67) | (6.61) | (25.93) | (23.04) | (16.70) |
| Capital Expenditures | 0.03 | 0.46 | 0.22 | 2.32 | 0.34 | 0.38 |
| Free Cash Flow* | (1.96) | (13.12) | (6.83) | (28.25) | (23.38) | (17.07) |
| Investing Cash Flow | (13.18) | 49.11 | 61.56 | (4.94) | 26.78 | 0.29 |
| Financing Cash Flow | 4.00 | (1.64) | (32.01) | 1.52 | (1.45) | 8.61 |
* Derived from reported values
